WAYNE, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. and Medovate Limited continue to partner on regional anesthesia education, announcing their joint sponsorship of a hands-on workshop at the American Society of Anesthesiologists (ASA) annual meeting, ANESTHESIOLOGY 2021, being held October 8-12 in San Diego. The one-hour workshop on October 9 at 12 pm, “Safety and simplicity in regional anesthesiology: promoting better outcomes,” will be presented by J. Douglas Jaffe, DO, FASA, Associate Professor of Anesthesiology, Atrium Health Wake Forest Baptist, an academic health system based in Winston-Salem, NC.
The workshop will demonstrate how new technologies in ultrasound and local anesthetic delivery are helping anesthesiologists provide safer regional anesthesia by reducing the potential risk of injury, promoting better outcomes for patients and simplifying processes, all which enhance patient care and satisfaction. Stations equipped with Konica Minolta’s SONIMAGE® HS2 Compact Ultrasound System and Medovate’s SAFIRA™ regional anesthesia injection technology will give attendees an opportunity to learn the technique or enhance their skills.
“As an anesthesiologist, our mantra of patient advocacy and patient safety is founded in ensuring a patient’s journey through a relatively uncomfortable procedure,” says Dr. Jaffe. “Given the current opioid epidemic, the need for regional anesthesia and analgesia procedures has increased exponentially. Carried with it, of course, is the risk of the procedure itself. It is exciting to see new technology available to help us reduce the risk of nerve injury and improve the patient experience.”
Regional anesthesia has demonstrated better post-operative analgesia, decreased opioid consumption and length of stay, early rehabilitation, fewer anesthesia-related side effects and high patient satisfaction compared to general anesthesia1,2.
The SONIMAGE HS2 System facilitates ultrasound-guided regional anesthesia procedures with an advanced algorithm, Simple Needle Visualization (SNV®), that improves needle visibility and increases accuracy in needle placement, both for in-plane and out-of-plane approaches. SNV also adjusts the sensitivity of needle visualization depending on the type of tissue.
In addition to helping limit pressure of injection, SAFIRA also transforms regional anesthesia into a one-physician procedure by allowing a single anesthesiologist to conduct the entire procedure. Previously, an assistant was required to inject the anesthetic solution at the required pressure while the anesthesiologist inserted the needle tip using ultrasound guidance. With SAFIRA, hospitals can potentially reduce costs associated with staffing an additional assistant for these procedures as well as potentially reduce the time per procedure by up to five minutes3.
- Cozowicz C, Poeran J, Zubizarreta N, et al. Trends in the Use of Regional Anesthesia: Neuraxial and Peripheral Nerve Blocks. Regional Anesthesia & Pain Medicine 2016;41:43-49.
- Albrecht, E. and Chin, K.J. Advances in regional anaesthesia and acute pain management: a narrative review. Anaesthesia, 2020; 75: e101-e110.
- Fong-Soe-Khioe R. Health Economic report Medovate commissioned written by a health economist from the University of East Anglia (UEA).
About Konica Minolta Healthcare Americas, Inc.
Konica Minolta Healthcare is a world-class provider and market leader in medical diagnostic imaging and healthcare information technology. With over 75 years of endless innovation, Konica Minolta is globally recognized as a leader providing cutting-edge technologies and comprehensive support aimed at providing real solutions to meet customer's needs and helping make better decisions sooner. Konica Minolta Healthcare Americas, Inc., headquartered in Wayne, NJ, is a unit of Konica Minolta, Inc. (TSE:4902). For more information on Konica Minolta Healthcare Americas, Inc., please visit https://healthcare.konicaminolta.us
About Medovate: www.medovate.co.uk
Medovate is a medical device company dedicated to the development and commercialisation of innovative medical technologies created within the NHS and beyond. Medovate identifies and works with high potential medtech innovations, providing the specialist management and technical resources, along with finance required to lead innovation development through clinical trials and regulatory approval. By providing funding and support at a crucial point in the development of innovative medical technologies, Medovate accelerates innovations to market in order to benefit patient care and healthcare delivery. The company has a strong portfolio relating to specialisms in anaesthesia, airway management, critical care and surgery. Medovate directly benefits the NHS by:
- Providing access to funding, support and expertise to enable innovations created within the NHS to reach the market
- Delivering commercial returns to the NHS organisations and inventors that created the technologies
Contact:
Mary Beth Massat
Massat Media
224.578.2388
https://healthcare.konicaminolta.us
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c5b4a85e-1a91-44ae-9aff-2d078b0ddf41
